Medistim ASA (LON:0OCD)
London
· Delayed Price · Currency is GBP · Price in NOK 160.50
-5.00 (-3.02%)
At close: Apr 15, 2025
Medistim ASA Revenue
In the year 2024, Medistim ASA had annual revenue of 556.16M NOK with 6.73% growth. Medistim ASA had revenue of 144.71M in the quarter ending December 31, 2024, with 11.00% growth.
Revenue
556.16M NOK
Revenue Growth
+6.73%
P/S Ratio
5.49
Revenue / Employee
3.61M NOK
Employees
154
Market Cap
214.53M GBP
Revenue Chart
* This company reports financials in NOK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 556.16M | 35.05M | 6.73% |
| Dec 31, 2023 | 521.11M | 34.85M | 7.17% |
| Dec 31, 2022 | 486.26M | 68.45M | 16.38% |
| Dec 31, 2021 | 417.82M | 61.61M | 17.30% |
| Dec 31, 2020 | 356.21M | -707.00K | -0.20% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.19B |
| GSK plc | 31.38B |
| Haleon | 11.23B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.83B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Oxford Nanopore Technologies | 183.19M |
Medistim ASA News
- 7 weeks ago - Medistim ASA (STU:MD1) Q4 2024 Earnings Call Highlights: Record Sales and Strategic Innovations ... - GuruFocus
- 7 weeks ago - Q4 2024 Medistim ASA Earnings Call Transcript - GuruFocus